B-CELL NON HODGKIN LYMPHOMA
Clinical trials for B-CELL NON HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B-CELL NON HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for B-CELL NON HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Pronged Cancer-Fighting cell therapy enters first human safety trial
Disease control Not yet recruitingThis is a first-in-human study to test the safety of a new type of CAR-T cell therapy for adults with B-cell cancers like lymphoma that have come back or stopped responding to other treatments. The therapy uses a patient's own modified immune cells designed to attack cancer by ta…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New immune cell attack tested for tough blood cancers
Disease control Not yet recruitingThis early-stage study is testing the safety of a new combination treatment for people with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior therapies. The treatment adds an experimental therapy—'natural killer' (NK) immune cells from a donor—…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug aims to boost Cancer-Fighting power of CAR-T therapy
Disease control Not yet recruitingThis early-stage study is testing whether a drug called N-803 is safe and can help patients with hard-to-treat B-cell lymphoma keep their cancer under control for longer after they've received CAR-T cell therapy. It will involve about 13 adults whose lymphoma improved after CAR-T…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: University of Utah • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC